JPRN-jRCT2031210315暂停2 期
[M20-370] A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of ABBV-154 in Subjects with Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment
Yamazaki Hayato0 个研究点目标入组 160 人开始时间: 2021年9月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 暂停
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 50age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Clinical diagnosis of Polymyalgia Rheumatica (PMR) and fulfillment of the 2012 European League Against
- •Rheumatism/American College of Rheumatology (EULAR/ACR) provisional classification criteria for PMR.
- •- Must have had at least 2 episodes of unequivocal PMR flare.
- •- Must be on a stable dose of prednisone.
- •- Must be willing to follow the protocol-defined glucocorticoid tapering regimen.
排除标准
- •- Have been treated with a prior TNF antagonist.
- •- Current use of immunomodulators other than prednisone.
研究者
相似试验
已完成
2 期
IM011-127 A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Subjects with Moderate to Severe Ulcerative Colitisinflammation of the large intestineulcers of the colon10018027NL-OMON51968Bristol-Myers Squibb10
进行中（未招募）
1 期
The effect of SJX-653 on Menopausal Hot FlashesEUCTR2019-002281-12-PLSojournix, Inc130
进行中（未招募）
1 期
The effect of SJX-653 on Menopausal Hot FlashesTreatment of moderate to severe vasomotor symptoms (VMS) associated with menopause.MedDRA version: 21.1Level: LLTClassification code 10027311Term: Menopause flushingSystem Organ Class: 100000004872EUCTR2019-002281-12-ESSojournix, Inc
进行中（未招募）
1 期
The effect of SJX-653 on Menopausal Hot FlashesEUCTR2019-002281-12-DESojournix, Inc66
进行中（未招募）
1 期
A norovirus vaccine studyPrevention of gastroenteritis caused by norovirusMedDRA version: 16.1Level: PTClassification code 10068189Term: Gastroenteritis norovirusSystem Organ Class: 10021881 - Infections and infestationsEUCTR2013-001419-64-BETakeda Vaccines (Montana), Inc.420